Liberator stock heads to NYSE
STUART, Fla. – Common stock of Liberator Medical Holdings has been approved to trade on the New York Stock Exchange starting Nov. 20, the company announced Nov. 18. Stock will trade under LBMH. “We are confident that our leading market positions and strong customer relationships, combined with the increased visibility of being listed on the NYSE, will help enhance value for all stakeholders,” stated Mark Libratore, Liberator CEO, in a release. Liberator, whose products include diabetic and ostomy supplies, posted strong earnings in the third quarter of 2013.